Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
June 30, 2024
Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors
Ayaka Otsuki, Masaki Kumondai, Daisuke Kobayashi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 20, 2019
Synthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation-Inhibitory Activity
Yusaku Nomura, Frédéric Thuaud, Daisuke Sekine, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
July 3, 2024
Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan
Motoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, et al.
Nature Communications
|
June 14, 2024
Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target
Kazuki Yamamoto, Toyotaka Sato, Aili Hao, et al.
Nature Communications
|
December 20, 2022
Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY
Takeshi Nakaya, Miyuki Yabe, Ellene H Mashalidis, et al.
International Journal of Hematology
|
November 25, 2022
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study
Yoshitaka Miyakawa, Kazunori Imada, Satoshi Ichikawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2011
Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Yasushi Onishi, Osamu Sasaki, Satoshi Ichikawa, et al.
Oncotarget
|
March 9, 2018
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits
Takashi Yoshida, Masaki Ri, Takashi Kanamori, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
December 25, 2009
[History of the histological staining survey in the Tokyo Metropolitan Hospital]
Satoshi Ichikawa, Kazuaki Enatsu, Seiko Yamane, et al.
Scientific Reports
|
May 31, 2022
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis
Koya Ono, Tohru Fujiwara, Kei Saito, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
June 30, 2024
Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors
Ayaka Otsuki, Masaki Kumondai, Daisuke Kobayashi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 20, 2019
Synthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation-Inhibitory Activity
Yusaku Nomura, Frédéric Thuaud, Daisuke Sekine, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
July 3, 2024
Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan
Motoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, et al.
Nature Communications
|
June 14, 2024
Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target
Kazuki Yamamoto, Toyotaka Sato, Aili Hao, et al.
Nature Communications
|
December 20, 2022
Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY
Takeshi Nakaya, Miyuki Yabe, Ellene H Mashalidis, et al.
International Journal of Hematology
|
November 25, 2022
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study
Yoshitaka Miyakawa, Kazunori Imada, Satoshi Ichikawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2011
Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Yasushi Onishi, Osamu Sasaki, Satoshi Ichikawa, et al.
Oncotarget
|
March 9, 2018
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits
Takashi Yoshida, Masaki Ri, Takashi Kanamori, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
December 25, 2009
[History of the histological staining survey in the Tokyo Metropolitan Hospital]
Satoshi Ichikawa, Kazuaki Enatsu, Seiko Yamane, et al.
Scientific Reports
|
May 31, 2022
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis
Koya Ono, Tohru Fujiwara, Kei Saito, et al.
Page
of 25